Archive for 2008/03


Asthma Medicines Often Not Prescribed As National Guidelines Recommend

More than a decade after national guidelines were issued for asthma treatment, some patients still don't receive prescriptions for the inhalers that experts say offer the safest and most effective long-term control of the disease, a new study suggests. Physicians' prescribing practices based on expert recommendations improved between 1998 and 2002 overall.
(more...)


Increasing Risk Of Community-Acquired Staph Pneumonia, Including MRSA

Preliminary research from the Centers for Disease Control and Prevention (CDC) suggests that community acquired pneumonia (CAP) caused by the Staphylococcus aureus bacterium may be more common than originally suspected, including that caused by antibiotic resistant strains. Researchers reported their findings at the 2008 International Conference on Emerging Infectious Diseases in Atlanta, Georgia."Over the last few years we have been receiving reports of a severe CAP caused by S.
(more...)


Breaking Down The Barriers To Good Asthma Care

Asthma UK is launching a set of new healthcare booklets which will help people from South Asian communities, who have been admitted to hospital with a potentially life-threatening asthma attack, avoid future emergency admissions. There are over 200 emergency admissions for asthma a day in the UK and people from South Asian communities are three times more likely than white people to be admitted to hospital for their asthma.
(more...)


How To Do Your Spring Cleaning If You Suffer From Asthma

Now that spring is officially upon us, it is that time of year when we all start to think about spritzing up our homes for the start of the new season but if you are one of the 5.2 million people in the UK who suffer from asthma, this is especially important. Dust, dirt and allergens tend to collect over the winter months causing a potentially dangerous build up of asthma triggers in your home.
(more...)


Global TB Drive Making Headway, But Very Slowly

The World Health Organization (WHO) report, Global Tuberculosis Control 2008, has found that the speed of the progress to stem the tuberculosis (TB) epidemic slowed slightly in 2006, the most recent year for which data were available. The new information documents a slowdown in progress on diagnosing people with TB. Between 2001 to 2005, the average rate at which new TB cases were detected was increasing by 6% per year; but between 2005 and 2006 that rate of increase was cut in half, to 3%.
(more...)


Approaches To Thoracic Surgery In The United Kingdom And Ireland, New Report

A new report from the Society for Cardiothoracic Surgery in Great Britain & Ireland (published by Dendrite Clinical Systems), has for the first time recorded the variations in activity and surgical approaches between thoracic surgical units in the United Kingdom and Ireland.
(more...)


Indonesia Is Country Worst Hit By Bird Flu - High Load Of Circulating Virus Could Lead To Mutation And Human Flu Pandemic

The prevalence of bird flu in Indonesia continues to be serious despite containment efforts undertaken by national authorities and the international community, FAO (Food and Agriculture Organization of the United Nations) warned today. Indonesia is the country worst hit by avian influenza.
(more...)


Using Botox To Treat Hypersalivation At The Montreal Children’s Hospital Of The MUHC

Botulinum toxin, also called Botox, is best known as one of the most commonly used molecules to reduce wrinkles. It is also known as one of the most poisonous naturally occurring substances.Now, thanks to Dr.
(more...)


MedImmune Advances Clinical Development Of Antibody Targeting Interleukin-9 In Patients With Asthma

MedImmune announced that its clinical program studying an investigational treatment targeting interleukin-9 (IL-9) has advanced with the start of a new trial in patients with asthma. The company initiated a Phase 2a clinical trial designed to assess the potential of its anti-IL-9 monoclonal antibody (MAb), MEDI-528, in patients with stable asthma and exercise-induced bronchoconstriction. This trial is the fourth study of this antibody in patients with asthma.
(more...)


Genaera Announces MedImmune Initiation Of Phase 2a Trial Of Antibody Targeting Interleukin-9 In Patients With Asthma

Genaera Corporation (Nasdaq: GENR) reported that development partner, MedImmune, has initiated its fourth phase 2a clinical trial of MEDI-528, an anti-IL-9 monoclonal antibody (MAb) targeting interleukin-9 (IL-9), in patients with asthma. This clinical trial is designed to assess the potential of MEDI-528 in patients with stable asthma and exercise-induced bronchoconstriction.
(more...)